Progression of Cognitive, Functional, and Neuropsychiatric Symptom Domains in a Population Cohort With Alzheimer Dementia: The Cache County Dementia Progression Study

Cited by (245)

Items 101–200 of 245

1. Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis
   Trine Holt Edwin, Bjørn Heine Strand, Karin Persson, Knut Engedal, Geir Selbæk, Anne‐Brita Knapskog · 2020 · International Psychogeriatrics
2. Cognitive and functional progression of dementia in two longitudinal studies
   Yuwei Wang, Miriam L. Haaksma, Inez H.G.B. Ramakers, Frans R.J. Verhey, Wiesje M. van der Flier, Philip Scheltens, Ingrid S. van Maurik, Marcel G. M. Olde Rikkert, Jeannie‐Marie Leoutsakos, René J. F. Melis · 2019 · International Journal of Geriatric Psychiatry
3. Total testosterone and neuropsychiatric symptoms in elderly men with Alzheimer’s disease
   James Richard Hall, April R. Wiechmann, Rebecca Lynn Cunningham, Leigh Ann Johnson, Melissa Edwards, Robert C. Barber, Meharvan Singh, Scott Winter, Sid E. O’Bryant · 2015 · Alzheimer s Research & Therapy
4. Vitamin B12 in Association with Antipsychotic Drugs Can Modulate the Expression of Pro-/Anti-Inflammatory Cytokines in Alzheimer Disease Patients
   Alireza Vakilian, Seyed Moein Razavi-Nasab, Ali Ravari, Tayebeh Mirzaei, Amir Moghadam Ahmadi, Nazanin Jalali, Reza Bahramabadi, Mohammad Taghi Rezayati, Amin Yazdanpanah-Ravari, Farhad Bahmaniar et al. · 2017 · NeuroImmunoModulation
5. Clinical Presentation, Diagnostic Features, and Mortality in Dementia with Lewy Bodies
   Sinéad Moylett, Annabel C. Price, Rudolf N. Cardinal · 2019 · Journal of Alzheimer s Disease
6. Sex differences in age-associated neurological diseases—A roadmap for reliable and high-yield research
   Anna Katharina Bonkhoff, Gillian Coughlan, Valentina Perosa, Kenda Alhadid, Markus D. Schirmer, Robert William Regenhardt, Susanne J. van Veluw, Rachel F. Buckley, Michael Fox, Natalia S. Rost · 2025 · Science Advances
7. Can Ketogenic Diet Improve Alzheimer's Disease? Association With Anxiety, Depression, and Glutamate System
   José Enrique de la Rubia Ortí, David Fernández, Félix Platero, María Pilar García-Pardo · 2021 · Frontiers in Nutrition
8. Global cognitive trajectory patterns in Alzheimer’s disease
   Carl I. Cohen, Barry Reisberg, Robert Yaffee · 2022 · International Psychogeriatrics
9. Effects of Gender and Apolipoprotein E on Novelty MMN and P3a in Healthy Elderly and Amnestic Mild Cognitive Impairment
   Gao, Lijuan, Chen, Jiu, Gu, Lihua, Shu, Hao, Wang, Zan, Liu, Duan, Yan, Yanna, Zhang, Zhijun · 2018 · Frontiers in Aging Neuroscience
10. A profile of The Clinical Course of Cognition and Comorbidity in Mild Cognitive Impairment and Dementia Study (The 4C study): two complementary longitudinal, clinical cohorts in the Netherlands
    Weiqi Liao, Renske E. G. Hamel, Marcel G. M. Olde Rikkert, Saskia M. Oosterveld, Pauline Aalten, Frans R.J. Verhey, Philip Scheltens, Nicole Sistermans, Yolande A.L. Pijnenburg, Wiesje M. van der Flier et al. · 2016 · BMC Neurology
11. Trajectories of neuropsychiatric symptoms over time in healthy volunteers and risk of MCI and dementia
    Jeannie‐Marie Leoutsakos, Elizabeth A. Wise, Constantine George Lyketsos, Gwenn S. Smith · 2019 · International Journal of Geriatric Psychiatry
12. Long-Term PM2.5 Exposure and Neurological Hospital Admissions in the Northeastern United States
    Marianthi‐Anna Kioumourtzoglou, Yun Wang, Francesca Dominici, Joel David Schwartz, Antonella Zanobetti · 2014 · ISEE Conference Abstracts
13. Sex-related differences in the relationship between β-amyloid and cognitive trajectories in older adults.
    Cutter A. Lindbergh, Hillblom Aging Network, Kaitlin Blackstone Casaletto, Adam M. Staffaroni, Renaud La Joie, Leonardo Iaccarino, Lauren Edwards, Elena Tsoy, Fanny M. Elahi, Samantha M. Walters et al. · 2020 · Neuropsychology
14. Clinical Trajectories of Neuropsychiatric Symptoms in Mild-Moderate to Advanced Dementia
    Isabel M. Castillo-García, Jorge López-Álvarez, Ricardo Osorio, Javier Olazarán, Maria I. Ramos García, Luis Agüera-Ortiz · 2022 · Journal of Alzheimer s Disease
15. The association of neuropsychiatric symptoms with regional brain volumes from patients in a tertiary multi-disciplinary memory clinic
    Milap A. Nowrangi, Christopher M. Marano, Kenichi Oishi, Susumu Mori, Haris Iqbal Sair, John D. Outen, Jeannie‐Marie Leoutsakos, Constantine George Lyketsos, Paul B. Rosenberg · 2020 · International Psychogeriatrics
16. Malnutrition and neuropsychiatric symptoms in dementia: the Cache County Dementia Progression Study
    Kaitlyn E. Kauzor, Mikaela Drewel, Hector Leonardo Gonzalez, Gail B. Rattinger, Alexandra G. Hammond, Heidi J. Wengreen, Constantine George Lyketsos, JoAnn T. Tschanz · 2023 · International Psychogeriatrics
17. Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID)
    Nathan Herrmann, Tetsuhiro Harimoto, Robert F Balshaw, Krista L. Lanctôt, The Canadian Outcomes Study in Dementia (COSID) Investigators (members)5 · 2015 · The Canadian Journal of Psychiatry
18. Epigenetic Biomarkers Driven by Environmental Toxins Associated with Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the United States: A Systematic Review
    Melanie Engstrom Newell, Anumitha Aravindan, Ayesha Babbrah, Rolf U. Halden · 2025 · Toxics
19. Exploring the relationship between patient-relevant outcomes and Alzheimer’s disease progression assessed using the clinical dementia rating scale: a systematic literature review
    Jeffrey L. Cummings, Julie Hviid Hahn‐Pedersen, Christian Stefan Eichinger, Caroline S. Freeman, Alice Clark, Luis Rafael Solís Tarazona, Krista L. Lanctôt · 2023 · Frontiers in Neurology
20. Minding the Gap: Exploring Neuroinflammatory and Microglial Sex Differences in Alzheimer’s Disease
    Erin G. Reed-Geaghan, Phaedra R. Keller-Norrell · 2023 · International Journal of Molecular Sciences
21. Human immunodeficiency virus‐1/simian immunodeficiency virus infection induces opening of pannexin‐1 channels resulting in neuronal synaptic compromise: A novel therapeutic opportunity to prevent NeuroHIV
    Anna Maria Górska, Maribel Donoso, Silvana Valdebenito, Brendan Prideaux, Suzanne E. Queen, Eliana Scemes, Janice E. Clements, Eliseo A. Eugenín · 2021 · Journal of Neurochemistry
22. Sex differences in the management of persons with dementia following a subnational primary care policy intervention
    Sourial, Nadia, Arsenault-Lapierre, Geneviève, Margo-Dermer, Eva, Henein, Mary, Vedel, Isabelle · 2020 · International Journal for Equity in Health
23. Sex differences in Alzheimer's disease risk: are we looking at the wrong hormones?
    Cynthia A. Munro · 2014 · International Psychogeriatrics
24. Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline
    Helen M. Hochstetler, Alzheimer’s Disease Neuroimaging Initiative, Paula T. Trzepacz, Shufang Wang, Peng Yu, Michael G. Case, David B. Henley, Elisabeth K. Degenhardt, Jeannie‐Marie Leoutsakos, Constantine George Lyketsos · 2016 · Journal of Alzheimer s Disease
25. A multicenter cohort study to investigate the factors associated with functional autonomy change in patients with cognitive complaint or neurocognitive disorders: the MEMORA study protocol
    the MEMORA group, Virginie Dauphinot, Claire Moutet, Isabelle Rouch, Mathieu Verdurand, Christelle Mouchoux, Floriane Delphin‐Combe, Sylvain Gaujard, Pierre Krolak‐Salmon · 2019 · BMC Geriatrics
26. Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice
    Theresa A. Lansdell, Hui Xu, J. Galligan, A. Dorrance · 2023 · Journal of Alzheimer's Disease
27. Comparison of behaviors characteristic of autism spectrum disorder behaviors and behavioral and psychiatric symptoms of dementia
    Elizabeth K. Rhodus, Justin M. Barber, Erin L. Abner, Shoshana H. Bardach, Allison Gibson, Gregory A. Jicha · 2020 · Aging & Mental Health
28. A life-course and multifactorial approach to Alzheimer’s disease: Implications for research, clinical assessment and intervention practices
    Martial Van der Linden, Anne‐Claude Juillerat Van der Linden · 2016 · Dementia
29. Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care
    Stephanie Behrens, Gail B. Rattinger, Sarah Schwartz, Joshua Matyi, Chelsea Sanders, M. Scott DeBerard, Constantine George Lyketsos, JoAnn T. Tschanz · 2018 · International Psychogeriatrics
30. Neuropsychiatric symptoms in severe dementia: Associations with specific cognitive domains the Cache County Dementia Progression Study
    William Rozum, Bryce Cooley, Elizabeth K. Vernon · 2019 · International Journal of Geriatric Psychiatry
31. An integrated approach to identifying sex-specific genes, transcription factors, and pathways relevant to Alzheimer's disease
    Adolfo López‐Cerdán, Zoraida Andreu, Marta R. Hidalgo, Irene Soler-Sáez, Antonio Porlan, Macarena Pozo‐Morales, Santiago León, María de la Iglesia-Vayá, Akiko Mikozami, Franca Rosa Guerini et al. · 2024 · Neurobiology of Disease
32. Cognitive behavioral therapy (CBT) for preventing Alzheimer’s disease
    Larry D. Reid, Faith E. Avens, Alicia A. Walf · 2017 · Behavioural Brain Research
33. Sex differences in the severity of neuropsychiatric symptoms and their relationship with clinico-demographic and psychosocial factors in patients with amnestic mild cognitive impairment and mild Alzheimer’s disease
    Keisuke Inamura, Shunichiro Shinagawa, Yuri Tsuneizumi, Tomoyuki Nagata, Kenji Tagai, Kazutaka Nukariya, Masahiro Shigeta · 2018 · Aging & Mental Health
34. Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class Analysis
    Julie Mouchet, Keith A. Betts, Mihaela V. Georgieva, Raluca Ionescu‐Ittu, Lesley M. Butler, Xavier M Teitsma, Paul Delmar, Thomas Kulalert, Jingjing Zhu, Neema Lema et al. · 2021 · Journal of Alzheimer s Disease
35. Mechanism of Action for Nonpharmacological Therapies for Individuals With Dementia: Implications for Practice and Research
    Sandy C. Burgener, Ying‐Ling Jao, Joel G. Anderson, Ann Bossen · 2015 · Research in Gerontological Nursing
36. Enhanced Association of Tau Pathology and Cognitive Impairment in Mild Cognitive Impairment Subjects with Behavior Symptoms
    Xinting Ge, Alzheimer’s Disease Neuroimaging Initiative, Yuchuan Qiao, Jiyoon Choi, Rema Raman, John M. Ringman, Yonggang Shi · 2022 · Journal of Alzheimer s Disease
37. Acute Psychogeriatric Inpatient Treatment Improves Neuropsychiatric Symptoms but Impairs the Level of Functioning in Patients with Dementia
    Hanna‐Mari Alanen, Anneli Pitkänen, Kirsti Suontaka-Jamalainen, Olli Kampman, Esa V. J. Leinonen · 2015 · Dementia and Geriatric Cognitive Disorders
38. Voices of Spouses Living with Partners with Neuropsychiatric Symptoms Related to Dementia
    Marie Tyrrell, Pernilla K. Hillerås, Kirsti Skovdahl, Bjöörn Fossum, Dorota Religa · 2017 · Dementia
39. Evaluation of the effects of anti-psychotic drugs on the expression of CD68 on the peripheral blood monocytes of Alzheimer patients with psychotic symptoms
    Reza Bahramabadi, Morteza Samadi, Alireza Vakilian, Elham Jafari, Mahmood Sheikh Fathollahi, Mohammad Kazemi Arababadi · 2017 · Life Sciences
40. SPIRIT advance care planning intervention in early stage dementias: An NIH stage I behavioral intervention development trial
    Mi‐Kyung Song, Sandra E. Ward, Kenneth W. Hepburn, Sudeshna Paul, Raj C. Shah, Darby Morhardt · 2018 · Contemporary Clinical Trials
41. Functional Decline and Body Composition Change in Older Adults With Alzheimer Disease
    Shunsuke Murata, Rei Ono, Taiki Sugimoto · 2020 · Alzheimer Disease & Associated Disorders
42. Neuropsychiatric Symptoms of Alzheimer’s Disease: An Anatomic-Genetic Framework for Treatment Development
    Milap A. Nowrangi, John D. Outen, John Kim, Dimitrios Avramopoulos, Constantine George Lyketsos, Paul B. Rosenberg · 2023 · Journal of Alzheimer s Disease
43. Age of Symptom Onset and Longitudinal Course of Sporadic Alzheimer’s Disease, Frontotemporal Dementia, and Vascular Dementia: A Systematic Review and Meta-Analysis
    Sally Day, Stefanie Roberts, Nathalie H. Launder, Anita Goh, Brian Draper, Alex Bahar‐Fuchs, Samantha M. Loi, Kate Laver, Adrienne Withall, Monica Cations · 2021 · Journal of Alzheimer s Disease
44. A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer’s Disease
    Paul B. Rosenberg, Halima Amjad, Muhammad Haroon Burhanullah, Milap A. Nowrangi, Ryan G. Vandrey, Mersania Jn Pierre, John D. Outen, Meghan Schultz, Christopher M. Marano, Marc Agronin et al. · 2025 · American Journal of Geriatric Psychiatry
45. Variability in spousal perceptions of caregiving and its relationship to older caregiver health outcomes
    Wesley B. Godfrey, Jeremy B. Yorgason, Yue Zhang, Bret L. Hicken, Wei Chen, Randall Rupper · 2018 · Journal of General Internal Medicine
46. MIAMI-AD (Methylation in Aging and Methylation in AD): an integrative knowledgebase that facilitates explorations of DNA methylation across sex, aging, and Alzheimer’s disease
    David Lukacsovich, Deirdre M. O’Shea, Hanchen Huang, Wei Zhang, Juan I. Young, X. Steven Chen, Sven‐Thorsten Dietrich, Brian W. Kunkle, Eden R. Martin, Lily Wang · 2024 · Database
47. The Histone H3 K4me3, K27me3, and K27ac Genome-Wide Distributions Are Differently Influenced by Sex in Brain Cortexes and Gastrocnemius of the Alzheimer’s Disease PSAPP Mouse Model
    Francesca Casciaro, Giuseppe Persico, Martina Rusin, Stefano Amatori, Claire B. Montgomery, Jennifer M. Rutkowsky, Jon Jay Ramsey, Gino A. Cortopassi, Mirco Fanelli, Marco Giorgio · 2021 · Epigenomes
48. The Impact of Marital Quality as Older Couples Adjust to Dementia Onset
    Meng L Huo, Kyungmin Kim, Sae Hwang Han · 2021 · The Journals of Gerontology Series B
49. Ventricular volume in relation to lumbar CSF levels of amyloid-β 1–42, tau and phosphorylated tau in iNPH, is there a dilution effect?
    Simon Lidén, Dan Farahmand, Katarina Laurell · 2022 · Fluids and Barriers of the CNS
50. Application of predictive models in boosting power of Alzheimer's disease clinical trials: A post hoc analysis of phase 3 solanezumab trials
    Ali Ezzati, Christos A. Davatzikos, David A. Wolk, Charles B. Hall, Christian Georg Habeck, Richard B. Lipton · 2022 · Alzheimer s & Dementia Translational Research & Clinical Interventions
51. Rapidly Versus Slowly Progressing Patients With Alzheimer’s Disease
    Jennifer N. Travis Seidl, Paul J. Massman · 2015 · American Journal of Alzheimer s Disease & Other Dementias®
52. Cognitive Decline in Alzheimer’s Disease Is Not Associated with APOE
    Katzourou, Ioanna, the Alzheimer’s Disease Neuroimaging Initiative, Leonenko, Ganna, Ivanov, Dobril, Meggy, Alun, Marshall, Rachel, Sims, Rebecca, Williams, Julie, Holmans, Peter, Escott-Price, Valentina · 2021 · Journal of Alzheimer's Disease
53. Cerebrospinal fluid β-amyloid1–42 correlates with rate of progression in Alzheimer’s disease
    George S. Vlachos, George P. Paraskevas, Dimitris Naoumis, Elizabeth Kapaki · 2012 · Journal of Neural Transmission
54. Dependence Scale for Alzheimer’s Disease
    Josep Garre‐Olmo, Joan Vilalta Franch, Laia Calvó‐Perxas · 2014 · Journal of Geriatric Psychiatry and Neurology
55. Amyloid positron emission tomography and cognitive reserve
    Matteo Bauckneht, Agnese Picco, Flavio Mariano Nobili, Silvia Daniela Morbelli · 2015 · World Journal of Radiology
56. Effect of dementia on receipt of influenza vaccine: a cohort study in French older adults using administrative data: 2007–2012
    Adeline Gallini, Nicola Coley, Sandrine Andrieu, Maryse Lapeyre‐Mestre, Virginie Gardette · 2017 · Fundamental and Clinical Pharmacology
57. A Montessori-based approach to treat behavioral and psychological symptoms in dementia
    JoAnn T. Tschanz, Alexandra G. Hammond · 2020 · International Psychogeriatrics
58. Sexual dimorphisms in innate immune activation markers in predementia Alzheimer’s disease
    Stephanie Lindgård Knudtzon, Kaja Nordengen, Lene Pålhaugen, Berglind Gísladóttir, Jonas Alexander Jarholm, Geir Bråthen, Ragnhild Eide Skogseth, Knut K. Waterloo, Per Selnes, Tormod Fladby et al. · 2025 · Brain Communications
59. Neurocognitive Disorders
    2022 · American Psychiatric Association Publishing eBooks
60. Sex‐specific topological structure associated with dementia via latent space estimation
    Selena Wang, Yiting Wang, Frederick H. Xu, Xinyuan Tian, Carolyn A. Fredericks, Li Shen, Yize Zhao, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s & Dementia
61. Association between Estradiol/Estrogen Receptors and Cognition: A Knowledge Domain Visualization Analysis of Trends
    Min Wu, Shujie Lou · 2023 · Medical Science Monitor
62. The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia
    Xin Du, Rachel Hill · 2016 · Journal of Molecular Neuroscience
63. Clinical Aspects of Neurobehavioral Symptoms of Dementia
    YoungSoon Yang, Nagaendran Kandiah, SangYun Kim, Yong Tae Kwak · 2020 · Dementia and Neurocognitive Disorders
64. Risk of Dementia in Patients Who Underwent Surgery under Neuraxial Anesthesia: A Nationwide Cohort Study
    Young Suk Kwon, Jaejun Lee, Sang‐Hwa Lee, Chulho Kim, Hyunjae Yu, Jong‐Hee Sohn, Dong‐Kyu Kim · 2021 · Journal of Personalized Medicine
65. Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil
    Stephen Z. Levine, Yair Goldberg, Kazufumi Yoshida, Myrto T. Samara, Andrea Cipriani, Takeshi Iwatsubo, Stefan Leucht, Toshiaki A. Furawaka · 2021 · European Psychiatry
66. Neuropsychiatric symptoms in people living with dementia receiving home health services
    Rebecca Lassell, Shih‐Yin Lin, Kimberly A. Convery, Jason Fletcher, Tracy L. Chippendale, Tessa M. Jones, Aditi Durga, James E. Galvin, Randall Rupper, Abraham Aizer Brody · 2023 · Journal of the American Geriatrics Society
67. Antidepressant Use and Progression of Mild to Moderate Alzheimer's Disease: Results from the European ICTUS Cohort
    Anne-Bahia Abdeljalil, Adélaïde De Mauléon, Marion Baziard, Bruno J. Vellas, Maryse Lapeyre‐Mestre, Maria Eugenia Soto · 2020 · Journal of the American Medical Directors Association
68. Missing apolipoprotein E ɛ4 allele associated with nonamnestic Alzheimer’s disease in a Tunisian population
    Saloua Fray, Afef Achouri-Rassas, Samir Belal, Taieb Ben Messaoud · 2022 · Journal of Genetics
69. Living with Dementia During the COVID-19 Pandemic: A Nationwide Survey Informing the American Experience
    Paul Arthur, Chih‐Ying Li, The Southern Indiana Dementia Workgroup · 2022 · Journal of Alzheimer s Disease Reports
70. A Literature Review of Methodologies Used in Randomized Clinical Trials of Agitation in Alzheimer's Disease
    Sanjay Dubé, J. Thomas Megerian, Richard I. Malamut · 2018 · The Journal of Prevention of Alzheimer s Disease
71. Neuropsychiatric Aspects of Alzheimer Dementia
    Milap A. Nowrangi · 2020 · Psychiatric Clinics of North America
72. A comparison of two approaches for modeling dementia progression in a changing patient context
    Nina Wubben, Miriam L. Haaksma, Inez H.G.B. Ramakers, Wiesje M. van der Flier, Frans R.J. Verhey, Marcel G. M. Olde Rikkert, René J. F. Melis · 2022 · International Journal of Geriatric Psychiatry
73. A semiparametric method for estimating the progression of cognitive decline in dementia
    Xiaoxia Li, Canan Bilen‐Green, Kambiz Farahmand, Linda K. Langley · 2018 · IISE Transactions on Healthcare Systems Engineering
74. Clinical factors predicting the rate of cognitive decline in a US memory clinic: An electronic health record study
    Roy Adams, Jeannie‐Marie Leoutsakos, Milap A. Nowrangi, Esther S. Oh, Paul B. Rosenberg, Konstantina Skolariki, Sevil Yaşar, Peter P. Zandi, Constantine George Lyketsos · 2025 · Alzheimer s & Dementia Translational Research & Clinical Interventions
75. Apolipoprotein ɛ4 Affects Multiple Domains of Neuropsychological Functioning in a Sample of Elderly Hispanics
    Diana C. Oviedo, Ambar R. Perez-Lao, Julio A. Flores-Cuadra, Alcibiades E. Villarreal, María B. Carreira, Shantal A. Grajales, Gabrielle B. Britton · 2020 · Journal of Alzheimer s Disease
76. Chapter 12. Anxiety, Obsessive-Compulsive, and Trauma-Related Disorders
    Michelle L. Conroy, Phelan E. Maruca-Sullivan, Chadrick E. Lane, Joan M. Cook · 2022 · American Psychiatric Association Publishing eBooks
77. Les démences au croisement des non-savoirs
    Anne‐Claude Juillerat Van der Linden · 2012 · Presses de l’EHESP eBooks
78. Measuring change in clinical profiles between hospital admission and discharge and predicting living arrangements at discharge for aged patients presenting behavioral and psychological symptoms of dementia
    Claudia Ortoleva Bucher, Nicole Dubuc, Armin von Gunten, Diane Morin · 2016 · Archives of Gerontology and Geriatrics
79. Supporting everyday functioning of people living with dementia: The role of care partners
    Laura N. Gitlin, Michael L. Bruneau · 2020 · Elsevier eBooks
80. Is bigger better? Towards a mechanistic understanding of neuropsychiatric symptoms in Alzheimer’s disease
    Milap A. Nowrangi, Paul B. Rosenberg · 2021 · International Psychogeriatrics
81. ["Ledderhose" disease. Plantar fibromatosis--clinical aspects].
    B Parnitzke, O Decker, Ulf P. Neumann · 1991 · PubMed
82. Memory trajectories by migration status and gender: A life-course intersectional perspective
    Silvia Loi, Giulia Tattarini, Jo Mhairi Hale · 2025 · Social Science & Medicine
83. Racial/ethnic differences in neuropsychiatric disturbances associated with incident dementia
    Elizabeth A. Wise, Haijuan Yan, Esther S. Oh, Jeannie‐Marie Leoutsakos · 2024 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
84. P2‐048: Plasma sphingomyelin is associated with cognitive progression in Alzheimer's Disease
    Michelle M. Mielke, Norman J. Haughey, Veera Venkata Ratnam Bandaru, Danielle D. Weinberg, Noman Zaidi, Valory Pavlik, Rachelle Smith Doody, Constantine George Lyketsos · 2011 · Alzheimer s & Dementia
85. Deterioro Cognitivo Leve y Enfermedad de Alzheimer: Revisión de conceptos
    IPC USMA · 2017 · Investigación y Pensamiento Crítico
86. Stroke and Dementia in Atrial Fibrillation
    Miljenka‐Jelena Jurašić, Sandra Morović, Sonja Antić, Iris Zavoreo, Vida Demari · 2012 · InTech eBooks
87. Neuropsychiatric symptoms in Alzheimer’s disease
    Banning · 2019 · Research Publications (Maastricht University)
88. Single-cell transcriptomic atlas of Alzheimer's disease middle temporal gyrus reveals region, cell type, and sex specificity of gene expression with novel genetic risk for MERTK in female
    Zhang, Le, Liu, Tianyu, He, Chuan H., Russo, Anthony, Coffey, Sarah, Yin, Dominic, Hsu, I-Uen, Zhang, Chi, Ye, Yixuan, Su, Chang et al. · 2026 · Journal of Alzheimer’s Disease
89. Creation and validation of a daily task reminder clock for people with dementia in a Pune dementia center
    Aarti Rahul Gaikwad, Sheela Upendra · 2025 · Journal of Education and Health Promotion
90. The Role of Medical Comorbidities on the Risk for Severe Dementia, Institutionalization, and Death in Alzheimer's Disease: A Population Study in Cache County, Utah
    Mac Gilbert · 2021 · Digital Commons - USU (Utah State University)
91. Dementia Due to Alzheimer’s Disease (AD)
    Arun K. Jha, Kaushik Mukhopadhaya · 2020 · Springer eBooks
92. Pharmacogenomics and Personalized Medicine in Alzheimer’s Disease
    Trevor Archer, Boo E. A. Johansson · 2013 · Springer eBooks
93. Chapter 8. Dementia and Mild Neurocognitive Disorders
    Elizabeth A. Wise, Constantine George Lyketsos · 2022 · American Psychiatric Association Publishing eBooks
94. Gender Differences Contribute to Variability of Serum Lipid Biomarkers for Alzheimer'S Disease
    Jie Kawakami, Stephen Piccolo, John S. K. Kauwe, Steven W. Graves · 2022 · Biomarkers in Medicine
95. Acetylcholinesterase Inhibition Properties and Docking Studies of Compounds Based on 6-Hydrazinyl-1,3,4-Trimethyl-1H-Pyrazolo[3,4-b]Pyridine
    Seyit Ali Güngör · 2023 · Journal of the Turkish Chemical Society Section A Chemistry
96. The Neuropathological Underpinnings of Neuropsychiatric Symptoms in Dementia
    Perminder Singh Sachdev · 2024 · American Journal of Geriatric Psychiatry
97. Risks and Outcomes of New Onset of Unmet Need for Mobility and Self-Care Daily Activities
    Laura Prouty Sands, Lina Lee, Xiaofan Zhu, Maham Khan, Pang Du · 2024 · The Gerontologist
98. Neuropsychological predictors of the outcome in non-demented subjects with cognitive complaints
    Dina Lúcia Gomes da Silva · 2012 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
99. Relationship of Nutritional Factors to Cognitive Decline in the Progression of Dementia: The Cache County Dementia Progression Study
    Chelsea Sanders · 2021 · Digital Commons - USU (Utah State University)
100. Mild Cognitive Impairment: Beyond Memory Dysfunction
     Andrea Tales, Antony J. Bayer, Stefan Krajcik, K. A. Jellinger · 2012 · International Journal of Alzheimer s Disease